Regeneron Pharmaceuticals
REGN
#284
Rank
ยฃ48.59 B
Marketcap
ยฃ444.53
Share price
-6.09%
Change (1 day)
-40.03%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : ยฃ6.51 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total liabilities are ยฃ6.51 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regeneron Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ6.69 B20.07%
2023-12-31ยฃ5.57 B3.03%
2022-12-31ยฃ5.41 B9.64%
2021-12-31ยฃ4.93 B9.67%
2020-12-31ยฃ4.50 B58.93%
2019-12-31ยฃ2.83 B20.81%
2018-12-31ยฃ2.34 B20.98%
2017-12-31ยฃ1.93 B-5.23%
2016-12-31ยฃ2.04 B55.12%
2015-12-31ยฃ1.31 B59.48%
2014-12-31ยฃ0.82 B36.55%
2013-12-31ยฃ0.60 B17.21%
2012-12-31ยฃ0.51 B-4.15%
2011-12-31ยฃ0.53 B48.17%
2010-12-31ยฃ0.36 B70.92%
2009-12-31ยฃ0.21 B3.06%
2008-12-31ยฃ0.20 B-13.8%
2007-12-31ยฃ0.23 B27.37%
2006-12-31ยฃ0.18 B4.81%
2005-12-31ยฃ0.17 B18.58%
2004-12-31ยฃ0.15 B-20.82%
2003-12-31ยฃ0.19 B24.79%
2002-12-31ยฃ0.15 B-3.04%
2001-12-31ยฃ0.15 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ66.63 B 922.65%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.23 B-50.36%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.78 B 34.83%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ84.19 B 1,192.13%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ45.05 B 591.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ44.31 B 580.15%๐Ÿ‡ซ๐Ÿ‡ท France